Prime Therapeutics is a pharmacy solutions company founded in 1998 by Blue Cross and Blue Shield plans. The company operates as a pharmacy benefit manager, serving millions of people across the United States through partnerships with health plans, employers, and government programs. Owned by health plans rather than Wall Street investors, Prime Therapeutics structures its operations around the interests of the plans and members it serves.
The company delivers value through pharmacy benefit management, which helps members access medications while controlling costs, and specialty pharmacy services that manage complex medications for serious conditions. Prime Therapeutics operates clinical programs designed to improve health outcomes and simplify pharmacy care delivery. Member education on prescription benefits forms another core component of its service model, ensuring people understand their coverage and options.
Prime Therapeutics combines clinical expertise with modern healthcare technology to address the practical challenges of medication access and affordability. The company's structure - as a diversified pharmacy organisation owned by health plans - positions it to align incentives with member health outcomes rather than external shareholders.
